The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis
- 1 September 1980
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 47 (3) , 411-417
- https://doi.org/10.1016/0022-510x(80)90094-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Serum creatine kinase and pyruvate kinase in duchenne muscular dystrophy carrier detectionMuscle & Nerve, 1979
- Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophiesJournal of the Neurological Sciences, 1978
- Pyruvate kinase: Diagnostic value in neuromuscular diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Use of Normal Daughters’ and Sisters’ Creatine Kinase Levels in Estimating Heterozygosity in Duchenne Muscular DystrophyHuman Heredity, 1977
- Use of Normal Daughters’ CPK Levels in the Estimation of Heterozygosity Risks in X-Linked Muscular DystrophiesHuman Heredity, 1975
- Serum pyruvate kinase in muscle disease and carrier statesNeurology, 1974
- The detection of carriers of X-linked muscular dystrophy genes: A review of some methods studied in Newcastle upon TyneJournal of the Neurological Sciences, 1971
- THE VALUE OF SERUM ENZYME DETERMINATIONS IN THE IDENTIFICATION OF DYSTROPHIC CARRIERSAnnals of the New York Academy of Sciences, 1966
- Serum enzyme studies in muscle disease: Part III Serum creatine kinase activity in relatives of patients with the Duchenne type of muscular dystrophyJournal of Neurology, Neurosurgery & Psychiatry, 1964
- SOME NOTES ON DISCRIMINATIONAnnals of Eugenics, 1946